Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | PRNP | P04156 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Clomazone SCHEMBL7584484 | 0.90 | MAPT (0.31) | BRD4MAPT | |
| Clomazone SCHEMBL7576387 | 0.89 | MAPT (0.31) | BRD4MAPT | |
| SCHEMBL38910 | 0.81 | ALDH1A1 (0.33) | MAPTLMNA | |
| SCHEMBL30750946 | 0.81 | ALDH1A1 (0.33) | MAPTLMNA | |
| SCHEMBL7561296 | 0.81 | ALDH1A1 (0.33) | MAPTLMNA | |
| SCHEMBL7576318 | 0.75 | NTRK1 (0.31) | — | |
| Clopyralid SCHEMBL7589112 | 0.74 | RIPK1 (0.34) | MAPT | |
| SCHEMBL7535199 | 0.74 | NTRK1 (0.37) | HTT | |
| Thidiazuron SCHEMBL7582326 | 0.74 | MEN1 (0.32) | MAPTLMNA | |
| Tebutam SCHEMBL7580831 | 0.74 | MEN1 (0.34) | MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | PPOX, ALAD, DDT | BRD4 4027/4885MAPT 1092/4885THRB 2326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.